|Articles|August 26, 2019
AAE Empowers HCP Identification by MS
Author(s)Cygnus Technologies
AAE and MS integration enables comprehensive HCP analysis, facilitates process development, and helps determine whether your HCP ELISA is fit for purpose of process monitoring and product lot release.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
EU Clears Subcutaneous Biologic for Lupus, Advancing Patient-Controlled Delivery
2
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
3
Developing Next-Gen Cell Lines Using Targeted Integration
4
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
5